ContextVision taps Toyo as Japanese distributor

TriMed Staff | | Health Imaging | Screening
ContextVision Inc. has made Toyo Corp. a distributor of its GOPView image enhancement products in Japan.

The pair's agreement allows Toyo to offer all of ContextVision´s GOPView image enhancement products to Japanese medical imaging vendors within the ultrasound, x-ray and MRI markets. Toyo will offer local customization and support of GOPView to suit modality, acquisition demands and customer preferences

ContextVision's GOPView image enhancement products are software-based and embedded in medical devices. They enable greater diagnostic accuracy while reducing eye fatigue for clinicians, the company said.

TriMed Staff

Related Content

Abbreviated MRI protocols present suitable alternatives for liver cancer screening
Routine abdominal CTs offer insight into cardiovascular risk
Screening efforts have helped avert millions of cancer-related deaths in recent decades
What breast density status can tell us about cardiovascular risk
FDA clears AI tool that flags signs of heart disease in chest CT scans
Patients without PCPs struggle to access lung cancer screening, despite eligibility

Around the web

Radiology Business
The biggest obstacles facing radiology business managers in 2025

RBMA President Peter Moffatt discusses declining reimbursement rates, recruiting challenges and the role of artificial intelligence in transforming the industry.

Cardiovascular Business
New cardiac prevention paradigm explored in TRANSFORM trial using AI and CCTA

Deepak Bhatt, MD, director of the Mount Sinai Fuster Heart Hospital and principal investigator of the TRANSFORM trial, explains an emerging technique for cardiac screening: combining coronary CT angiography with artificial intelligence for plaque analysis to create an approach similar to mammography.

Cardiovascular Business
Cardiology practices pay $17.7M to settle fraud allegations brought on by whistleblowers

A total of 16 cardiology practices from 12 states settled with the DOJ to resolve allegations they overbilled Medicare for imaging agents used to diagnose cardiovascular disease.